ALFA Finder| Revenue growth | FY26 GWP grew 16% YoY; Fresh retail growth 37% YoY. |
|---|---|
| Margins | Combined ratio improved to 98.8% in FY26 from 101.1% in FY25. |
| Demand visibility | Strong; Retail Health outpacing broader non-life industry growth. |
| Management confidence | High confidence in disciplined execution and risk-first balance of growth/ROE. |
Growth
FY26 PAT grew 16% YoY to ₹911 Cr. Q4 FY26 GWP increased 17% YoY to ₹6,259 Cr.
Outlook
Targeting 1 million agents in 2 years; focus on mid-to-high teen ROE and sustainable high-teen growth.
Risks
Mark-to-market equity losses of ₹558 Cr in Q4; potential seasonal claims recurrence in FY27.
Earnings Call filed with NSE, NSE: STARHEALTH. Summary written with AI assistance from the document.
Star Health and Allied Insurance Company Ltd: key numbers
- Share price
- ₹557.80
- Market cap
- ₹32,781 Cr
- Revenue (annual)
- ₹17,825 Cr
- Net profit (annual)
- ₹557.0 Cr
- P/E (TTM)
- 31.1×Sector 20.8×
- Promoter holding
- 58.00%-0.01% QoQ
- FII holding
- 15.86%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Health and Allied Insurance Company Ltd
All →Star Health and Allied Insurance Company Capital Structure Change
Star Health received IRDAI approval for HDFC Mutual Fund schemes to acquire equity up to 9.99% of paid-up capital, up from 4.49%. The approval extends the fund's existing stake and does not involve a stated rupee amount.
Star Health and Allied Insurance Company Results Update
Star Health reported Normalised PAT of ₹390 Crores in Q2 FY27, up 70% YoY. H1 FY27 PAT stood at ₹815 Crores, up 57% YoY.
Star Health and Allied Insurance Company Earnings Call Transcript: Key Takeaways
Star Health reported a significant structural turnaround with underwriting profitability for the fifth consecutive quarter.
- Call
- Guides 20% growth
Star Health and Allied Insurance Company Other Announcement
Star Health filed a NIL Reg 54 security cover certificate for unsecured NCDs. No secured debt is covered, so this is routine compliance.
Star Health and Allied Insurance Company Investor Presentation: Key Takeaways
H1 FY27 PAT ₹815 Cr (+57%); CISR improved to 97.9% from 100.3%; underwriting result ₹210 Cr vs loss ₹24 Cr. Retail fresh GWP +36%, driven by agency and D2C. Reported profit includes ₹229 Cr MTM gain.
Star Health and Allied Insurance Company Promoter Reclassification
Star Health's board approved reclassifying Sthitaprajna Advisors LLP from promoter group to public shareholder category. The move is subject to requisite regulatory approvals.